Here’s Your Free Download
Thank you for your interest in our “What makes a compliant Phase III and pre-launch patient strategy” publication. Please click on the link below to download it:
You will also receive my monthly video blog If Medicines Could Talk™. The first episode is an interview with Christoph Thalheim of the European Multiple Sclerosis Platform, one of the principal authors, who talks about the patient perpsective on transparency, patient registries and HTA training for patient groups.
If Medicines Could Talk™ is a monthly video blog discussing patient engagement in early drug development. Each episode will feature an interview with a patient group or a related stakeholder. The second episode is with Keith Allan, ex VP Patient Advocacy at Novartis, talking about the Industry perspectives and another one of the study authors. If you decide you no longer wish to receive these videos, you may unsubscribe at any time.